Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer

The landscape of advanced prostate cancer treatment has evolved tremendously in past decades. The treatment paradigm has shifted from androgen deprivation therapy (ADT) alone to doublet combinations comprising ADT with docetaxel or an androgen receptor inhibitor, and now triplet therapy involving al...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kenneth, Kostos, Louise, Azad, Arun A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415497/
https://www.ncbi.nlm.nih.gov/pubmed/36029329
http://dx.doi.org/10.1007/s00345-022-04135-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415497/
https://www.ncbi.nlm.nih.gov/pubmed/36029329
http://dx.doi.org/10.1007/s00345-022-04135-8

Ejemplares similares